Le Lézard
Classified in: Health
Subject: PDT

Board Certified Celebrity Dermatologist Dr. Ava Shamban Launches Althaea Skin


Redefining Beauty Through the Power of Clock Genes

LOS ANGELES, May 1, 2024 /PRNewswire/ -- Driven by groundbreaking research and a profound understanding of the skin's clock genes, renowned board-certified celebrity dermatologist Dr. Ava Shamban proudly presents Althaea Skin, a revolutionary brand that ushers in a new era of clinical-grade skin care launching on May 1, 2024. Althaea Skin redefines beauty and wellness by offering a diverse range of products meticulously designed to synchronize with the skin's circadian rhythm, providing precisely what it needs, precisely when it needs it.

The Power of Clock Genes
Grounded in award-winning dermatologic and genetic research, Althaea Skin's core philosophy revolves around the extraordinary influence of clock genes embedded within the DNA of our skin cells. These genes act as the conductors of the skin's daily cycle, directing it through the intricate ballet of daytime tasks and nighttime duties. However, the relentless environmental stressors of modern life often disrupt this harmonious rhythm, leaving the skin fatigued and lackluster.

Althaea Skin restores this delicate balance, ensuring a healthy and balanced complexion that transcends traditional skincare boundaries. As the Greek word "ALTHAEA" implies, this brand is a true healer, offering an innovative approach to beauty and wellness that seamlessly integrates into your daily life.

A true scientific breakthrough, Althaea Skin is comprised of two proprietary complexes:

Solar Synq Technology® is a combination of unique ingredients that support the Clock Genes daytime function of defense against environmental aggressors optimally using antioxidants to protect skin.

Lunar Synq Technology® is a proprietary complex that restores the skin's ability to best perform the nighttime tasks of repair and renewal. 

Discover Althaea Skin's Product Lineup:

About Althaea Skin:
Althaea Skin, founded by renowned board-certified celebrity dermatologist Dr. Ava Shamban, is a revolutionary brand that has redefined skincare through groundbreaking research on clock genes and circadian rhythms. Their innovative approach synchronizes with the skin's natural rhythm, ensuring optimal skincare results. Althaea Skin's commitment to effectiveness, accessibility, and environmental consciousness sets a new standard for beauty and wellness.

About Dr. Ava Shamban:
Althaea Skin has been founded by dermatologist Dr. Ava Shamban, who is a renowned board-certified Dermatologist, best-selling author, anti-aging expert, and prejuvenation proponent. Founder of Ava MD Dermatology and SKIN FIVE, she also runs the Ava T. Shamban Research Clinic, where she is the principal investigator on clinical trials for Allergan, Evolus, Merz, Galderma, Revance and others engaged in the pipeline of future treatments, products, technologies, and protocols.

For media inquiries, interviews, product samples, or further information, please contact Michele Marie PR: [email protected]

SOURCE Althaea Skin


These press releases may also interest you

at 16:05
Nutcracker Therapeutics, Inc., a biotechnology company dedicated to developing transformative RNA therapies through its proprietary technology platform, today detailed data presented by its partners at the University of California, San Francisco...

at 16:05
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a global messenger RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases, today...

at 16:05
Omeros Corporation , a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting immunologic disorders including...

at 16:05
VBI Vaccines Inc. (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today provided a business update and announced financial results for the quarter ended March 31, 2024. "To...

at 16:02
K-Bro Linen Inc. (the "Corporation") announced today a dividend of 10.00 cents CDN per common share of the Corporation for the period from May 1 to 31, 2024, to be paid on June 14, 2024 to holders of record of common shares on May 31, 2024. The...

at 16:01
Kodiak Sciences Inc. , today reported business highlights and financial results for the quarter ended March 31, 2024. "We continue to make excellent operational progress with our three clinical programs of tarcocimab, KSI-501 and KSI-101, as well as...



News published on and distributed by: